|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Revvity, Inc. |
RVTY |
714046109 |
657 |
$92,104.83 |
2.98% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
3,577 |
$88,456.08 |
2.86% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,896 |
$86,581.63 |
2.80% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
229 |
$83,585.00 |
2.71% |
| Baxter International Inc. |
BAX |
071813109 |
3,441 |
$81,586.11 |
2.64% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
6,834 |
$81,137.36 |
2.63% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
211 |
$79,758.00 |
2.58% |
| DexCom, Inc. |
DXCM |
252131107 |
921 |
$79,620.45 |
2.58% |
| Agilent Technologies, Inc. |
A |
00846U101 |
513 |
$77,088.51 |
2.50% |
| Olympus Corporation |
7733.JP |
J61240107 |
6,040 |
$76,909.18 |
2.49% |
| Waters Corporation |
WAT |
941848103 |
184 |
$76,744.56 |
2.49% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
118 |
$75,684.02 |
2.45% |
| LivaNova Plc |
LIVN |
G5509L101 |
940 |
$74,701.80 |
2.42% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
864 |
$74,459.52 |
2.41% |
| Becton, Dickinson and Company |
BDX |
075887109 |
382 |
$71,021.44 |
2.30% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
255 |
$71,068.64 |
2.30% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,939 |
$67,133.72 |
2.17% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,616 |
$65,303.56 |
2.12% |
| Danaher Corporation |
DHR |
235851102 |
310 |
$64,901.60 |
2.10% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
757 |
$64,905.18 |
2.10% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
295 |
$64,687.03 |
2.10% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
552 |
$64,692.13 |
2.10% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$64,482.43 |
2.09% |
| Teleflex Incorporated |
TFX |
879369106 |
498 |
$64,251.96 |
2.08% |
| Medtronic Plc |
MDT |
G5960L103 |
676 |
$63,375.00 |
2.05% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
633 |
$62,293.53 |
2.02% |
| Abbott Laboratories |
ABT |
002824100 |
588 |
$59,993.64 |
1.94% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
45 |
$59,868.00 |
1.94% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,332 |
$59,753.07 |
1.94% |
| ResMed Inc. |
RMD |
761152107 |
258 |
$59,195.52 |
1.92% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
877 |
$56,823.47 |
1.84% |
| Penumbra, Inc. |
PEN |
70975L107 |
178 |
$56,680.54 |
1.84% |
| Steris Plc |
STE |
G8473T100 |
265 |
$55,724.20 |
1.80% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
807 |
$51,704.49 |
1.67% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,073 |
$51,628.83 |
1.67% |
| Alcon Inc. |
ALC.SW |
H01301128 |
756 |
$50,947.82 |
1.65% |
| Align Technology, Inc. |
ALGN |
016255101 |
340 |
$49,980.00 |
1.62% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
130 |
$49,030.80 |
1.59% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
3,516 |
$49,153.18 |
1.59% |
| Stryker Corporation |
SYK |
863667101 |
174 |
$48,981.00 |
1.59% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
652 |
$48,697.88 |
1.58% |
| Cochlear Limited |
COH.AU |
Q25953102 |
484 |
$47,090.80 |
1.53% |
| BioMerieux |
BIM.FP |
F1149Y232 |
558 |
$46,882.11 |
1.52% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$44,546.84 |
1.44% |
| The Cooper Companies, Inc. |
COO |
216648501 |
828 |
$44,107.56 |
1.43% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$42,326.30 |
1.37% |
| Boston Scientific Corporation |
BSX |
101137107 |
955 |
$41,895.85 |
1.36% |
| Insulet Corporation |
PODD |
45784P101 |
300 |
$41,772.00 |
1.35% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
514 |
$41,243.36 |
1.34% |
| US Dollar |
$USD |
|
12,931 |
$12,931.05 |
0.42% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|